Who is sponsoring NCT03613077?

NCT03613077 is sponsored by Institut Straumann AG.

What drugs are being tested in NCT03613077?

Interventions in NCT03613077: surgical placement of an endosteal implant.

What condition does NCT03613077 study?

NCT03613077 studies Surgical Operation With Implant of Artificial Internal Device.

Is NCT03613077 still recruiting?

NCT03613077 is currently completed. Last updated 9 January 2026.

Last reviewed 2026-01-09 · How we verify

NCT03613077: BLX_NIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

Completed Last updated 9 January 2026

What this trial tests

trial testing surgical placement of an endosteal implant in Surgical Operation With Implant of Artificial Internal Device in 153 participants. Completed in 21 August 2025.

Timeline

14 May 2018

Primary endpoint
2 February 2020

21 August 2025

Quick facts

Lead sponsor	Institut Straumann AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	153
Start date	14 May 2018
Primary completion	2 February 2020
Estimated completion	21 August 2025
Sites	1 location across Germany

Drugs / interventions tested

surgical placement of an endosteal implant

Conditions studied

Surgical Operation With Implant of Artificial Internal Device — all drugs for Surgical Operation With Implant of Artificial Internal Device →

Sponsor

Institut Straumann AG

Who can join

18 and older, any sex, with Surgical Operation With Implant of Artificial Internal Device. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Institut Straumann AG trials

Trials by the same sponsor.

NCT03737357 — Dental Implants With a SLActive® vs. SLA® Surface · NA · completed
NCT03908177 — Comparison of Clinical Performance and Safety of Zirconia vs. Titanium Implants: a Multi-national RCT. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03613077 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut Straumann AG
Last refreshed: 9 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03613077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing